Does dysbiosis-associated elevated fecal sIgA prime intestinal mast cells and increase histamine-mediated reactivity?

The relationship between intestinal dysbiosis and heightened immune sensitivity is well-documented, centered on the role of secretory IgA (sIgA) as a mediator between the microbiome and the host immune system. In a healthy state, sIgA maintains homeostasis; however, in the presence of dysbiosis, its elevation serves as a critical biomarker for mucosal immune activation.

Clinical evidence and sIgA dynamics

Elevated levels of fecal sIgA are clinical indicators of an active immune response to microbial instability or pathobionts. Research in patients with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) shows a significant correlation between increased sIgA-coated bacteria and symptom severity. This elevation reflects the host's attempt to manage microbial breaches of the intestinal barrier and the inflammatory signaling triggered by specific bacterial antigens and metabolites.

Mechanistic pathways of mast cell priming

Mucosal immune activation leads to the priming of intestinal mast cells through several distinct molecular pathways:

• Cytokine Signaling: Activation stimulates Th2 cells and mast cells to release type 2 cytokines, specifically IL-4 and IL-13. These cytokines sensitize mast cells and promote their proliferation.
• Epithelial Alarmins: Barrier stress triggers the release of alarmins such as IL-33, TSLP, and IL-25. IL-33 is particularly potent, increasing chromatin accessibility at NF-κB and AP-1 motifs, which lowers the threshold for mast cell degranulation and upregulates the production of inflammatory mediators like IL-1β.
• Histamine Reactivity: Once primed, mast cells release histamine upon subsequent stimulation. This histamine activates H1, H2, and H4 receptors on enteric nerves and smooth muscle. Even without an increase in total mast cell count, the close proximity of activated mast cells to colonic nerves drives visceral hypersensitivity and altered motility.

Bottom line

Dysbiosis-driven elevation of fecal sIgA is a valid marker of mucosal immune activation. This state primes intestinal mast cells via IL-33 and Th2 cytokines, significantly increasing histamine-mediated reactivity and visceral sensitivity.